The CYP2J2-EETs-sEH metabolic pathway has been shown in mice to have a beneficial effect on adiposity, non-alcoholic fatty liver disease, systemic inflammation, and insulin resistance [73,74,75]. The gene discussed is EPHX2; the disease is metabolic dysfunction-associated steatotic liver disease.